Modified Definition of Autism Too Consequential to Rush Into Print: View

Editorials

Illustration by Bloomberg View

By the Editors Mon Feb 06 00:00:00 GMT 2012

When is a person just a little different, and when is his peculiarity a symptom of a disabling disorder?

An expert panel has taken a new crack at that question, proposing a redefinition of autism and related conditions for the manual used by U.S. mental health professionals. The plan has aroused fears that it may strip many people of a diagnosis and thus the insurance and government benefits that can go with it.

So far, it’s not certain whether this would be the result. But until the consequences are known, it’s premature for the American Psychiatric Association to change the autism diagnosis in the fifth edition of its Diagnostic and Statistical Manual of Mental Disorders.

The stakes are high. About 1 percent of American children are affected by autism and related disorders, according to the Centers for Disease Control. This represents a dramatic increase, which has been attributed to changes made to the diagnostic manual in 1994. That version, the DSM-IV, carved out a separate diagnosis for Asperger’s disorder, typified by social awkwardness and an all-absorbing interest in specific topics.

For the DSM-5 (the manual will use Arabic numerals from now on), the APA’s autism working group has proposed combining classic autism, Asperger’s and two related conditions into autism spectrum disorder and has tightened the requirements for arriving at the new diagnosis. For example, to diagnose an Asperger’s case under the proposed changes, a clinician would have to identify impairment in five of seven categories rather than only three in eight, as under DSM-IV.

The autism working group is confident that its language would not disqualify those who are truly autistic. It cites still-unpublished research indicating that the DSM-IV criteria, if literally applied, lead to diagnoses that two clinicians cannot agree are warranted.

Panelists cite additional analysis showing that those whose diagnoses are confirmed by two clinicians also meet the criteria of the proposed DSM-5 rules.

Unfortunately, the APA doesn’t plan to publish this research until the DSM-5 rules are final. That’s backward. Far too many people are potentially affected by the planned changes for the working group to say, in essence, “Trust us on the evidence.”

Psychiatrists know there is a relatively simple way to clear all this up. In addition to releasing the research, the APA could order a modest new study that uses a stronger means of determining who is truly autistic than clinician judgment, a method so weak the APA gives it no validity. The study would screen children with autism characteristics using both DSM-IV and the proposed DSM-5 criteria. To check the validity of the diagnoses, researchers could rely on family history, a strong validator because the disorder runs in families.

If a portion of children lose the diagnosis in the switch to DSM-5, it should be relatively easy to tell how many of them were falsely diagnosed under DSM-IV. They would be the ones without a family history of autism. If significant numbers had such a history, however, it would suggest that the proposed new standards would deprive children who genuinely have autism disorder of the care they need. Then the APA would have an opportunity to change the rules before they did any harm.

It’s conceivable that such a study could be done in time for a full airing of the issues so that the APA could still make its Dec. 31 deadline for the DSM-5. If not, the organization should resist pushing through, without sufficient evidence, a change that would mean the end of insurance, education and social support for children who need it. Although this might save some tax dollars in the short term, it would cost society more in the long run, because without support these children would be less likely to succeed as independently functioning adults.

The reason the APA dropped the Roman numerals this time around was to allow for interim revisions of its manual. The matter of autism disorder could be a perfect subject for DSM 5.1.

Read more opinion online from Bloomberg View.

To contact the Bloomberg View editorial board: view@bloomberg.net.

Please enable JavaScript to view the comments powered by Disqus.

View post:
Modified Definition of Autism Too Consequential to Rush Into Print: View

Autism needs not met for Brimbank students

BRIMBANK has the highest number of students with autism in the west but few local support services to help them, a report has found.

Documents from the Thornton report, obtained through Freedom of Information by Greens MP Colleen Hartland, found Brimbank has the highest number of students in the Program for Students with a Disability, at 32 per cent.

Wyndham was next, with 24 per cent, and Melton at 19 per cent.

Community consultation outlined in the documents revealed family frustrations over education needs not being met.

The report found the location of services specific to autism spectrum disorder (ASD) or of general specialist schools does not correspond to where students live.

Last month, Education Minister Martin Dixon announced that Laverton P-12 College was the preferred site to establish a P-12 school for students with an autism spectrum disorder.

Mr Dixon said the proposed stand-alone school would be located alongside the Laverton P-12 College, and less than 1km from the Western Autistic P-3 school.

But Autism Angels committee member Despina Havelas said parents in Brimbank and Melton were crushed by the decision.

“One of the core things in life is you want your child to have a good education,” she said.

“Most parents know Laverton is too far away, and too long for these children to be sitting on a school bus.”

Ms Hartland said the problem was “bigger than these documents show”.

“It is impossible to see the true scale of the problem as not all students with autism are included,” she said.

“The Government needs to stop delaying, build the P-12 school and improve support for students in mainstream schools.”

Western Metropolitan MP Bernie Finn said it was an ongoing problem.

“We could spend $100 million on education in the west and still be behind the eight-ball,” he said.

More here:
Autism needs not met for Brimbank students

Living with Sickle Cell Disease – Video

21-01-2011 14:02 Meet Damali and Amiel Reid, two siblings who are living with sickle cell anemia, and learn about their struggles with the disease and their hopes for a cure. Damali, 33, has started a support group for other people living with the disease, and Amiel, 16, has spent a summer learning about sickle cell by working in the lab of Dr. George Daley, Director of Stem Cell Transplantation at Children's Hospital Boston. Give patients like Damali and Amiel hope by supporting stem cell research at Children's Hospital Boston. Please visit the stem cell website stemcell101.org for more information about how you can help.

See the original post here:
Living with Sickle Cell Disease - Video

Endothelial Progenitor Stem Cells in Lupus Cardiovascular Disease – Video

07-02-2011 13:44 Systemic lupus is associated with significant increases in premature heart attacks. Dr. Mariana Kaplan and her team at the University of Michigan Health Systems in Ann Arbor studied the abnormal function of stem cells that repair damaged blood vessels, an important factor implicated in heart disease in lupus. This study investigated the potential mechanisms by which abnormal vascular repair occurs in lupus and could contribute to designing treatments aimed at decreasing the risk of this potentially fatal complication. In this video, recorded during the 2010 American College of Rheumatology Annual Scientific Meeting in Atlanta, Georgia, Dr. Kaplan explains some of her findings, possible implications for the data she developed from the LFA funded study, and the next steps in this research.

Read more:
Endothelial Progenitor Stem Cells in Lupus Cardiovascular Disease - Video

Leeza Gibbons: The California Stem Cell Agency's Investment in Neurodegenerative Diseases – Video

25-05-2011 10:37 (Part 2 of 7) Leeza Gibbons, member of the California Stem Cell Agency's Governing Board, gave the keynote presentation at "Synapses Firing: Connections Made", a patient advocacy event hosted by the California stem cell funding agency (CIRM). The 100+ people in attendance heard from patient advocates about living with neurodegenerative disease and from scientists about recent progress in stem cell research that may lead to new treatments. The event was held at UC-Irvine's Sue and Bill Gross Stem Cell Research Center

Excerpt from:
Leeza Gibbons: The California Stem Cell Agency's Investment in Neurodegenerative Diseases - Video

Leeza Gibbons: The California Stem Cell Agency’s Investment in Neurodegenerative Diseases – Video

25-05-2011 10:37 (Part 2 of 7) Leeza Gibbons, member of the California Stem Cell Agency's Governing Board, gave the keynote presentation at "Synapses Firing: Connections Made", a patient advocacy event hosted by the California stem cell funding agency (CIRM). The 100+ people in attendance heard from patient advocates about living with neurodegenerative disease and from scientists about recent progress in stem cell research that may lead to new treatments. The event was held at UC-Irvine's Sue and Bill Gross Stem Cell Research Center

Excerpt from:
Leeza Gibbons: The California Stem Cell Agency's Investment in Neurodegenerative Diseases - Video

Huntington's Disease: Stem Cell Treatment Strategies at UC Davis – Video

09-06-2011 12:23 (Part 3 or 5) Jan Nolta, Ph.D., spoke at the "Spotlight on Huntington's Disease," an educational event presented at the CIRM Governing Board meeting on March 11, 2010. Nolta is director of the Stem Cell Program and Institute for Regenerative Cures at the University of California, Davis. She was introduced by Claire Pomeroy, MD, MBA The CIRM-hosted event was presented in partnership with UC Davis at the California State Capitol Building. To view the other videos in this playlists, go to: http://www.youtube.com

Here is the original post:
Huntington's Disease: Stem Cell Treatment Strategies at UC Davis - Video

Huntington’s Disease: Stem Cell Treatment Strategies at UC Davis – Video

09-06-2011 12:23 (Part 3 or 5) Jan Nolta, Ph.D., spoke at the "Spotlight on Huntington's Disease," an educational event presented at the CIRM Governing Board meeting on March 11, 2010. Nolta is director of the Stem Cell Program and Institute for Regenerative Cures at the University of California, Davis. She was introduced by Claire Pomeroy, MD, MBA The CIRM-hosted event was presented in partnership with UC Davis at the California State Capitol Building. To view the other videos in this playlists, go to: http://www.youtube.com

Here is the original post:
Huntington's Disease: Stem Cell Treatment Strategies at UC Davis - Video

Batten Disease: Spotlight on Stem Cell Research – A Father's Story – Video

12-06-2011 17:26 (Part 4 of 4) Tony Ferrandino spoke at the "Spotlight on Batten Disease," an educational event presented at the CIRM Governing Board Meeting on August 13, 2008. Ferrandino's son, Drew, was diagnosed with Batten disease in January 2007. Ferrandino spoke about his family's journey to identify Drew's condition and to seek out a treatment. Drew is enrolled in a stem cell trial being run by StemCells, Inc. To view the other videos in this playlist, go to: http://www.youtube.com

See the rest here:
Batten Disease: Spotlight on Stem Cell Research - A Father's Story - Video

Alzheimer's Disease: Spotlight on Stem Cell Research – Leeza Gibbons – Video

10-06-2011 22:33 (Part 1 of 4) Robert Klein, JD and Leeza Gibbons, gave the welcoming remarks for the "Spotlight on Alzheimer's Disease," an educational event presented at the CIRM Governing Board meeting on December 10, 2008. Klein is Chair of the CIRM Governing Board and President of Klein Financial Corporation. Gibbons is a patient advocate member of the CIRM Governing Board and is the founder of the Leeza Gibbons Memory Foundation. The CIRM-hosted event was presented in partnership with the University of California, Irvine at the UC Irvine Student Center.

Excerpt from:
Alzheimer's Disease: Spotlight on Stem Cell Research - Leeza Gibbons - Video

Batten Disease: Spotlight on Stem Cell Research – A Father’s Story – Video

12-06-2011 17:26 (Part 4 of 4) Tony Ferrandino spoke at the "Spotlight on Batten Disease," an educational event presented at the CIRM Governing Board Meeting on August 13, 2008. Ferrandino's son, Drew, was diagnosed with Batten disease in January 2007. Ferrandino spoke about his family's journey to identify Drew's condition and to seek out a treatment. Drew is enrolled in a stem cell trial being run by StemCells, Inc. To view the other videos in this playlist, go to: http://www.youtube.com

See the rest here:
Batten Disease: Spotlight on Stem Cell Research - A Father's Story - Video

Alzheimer’s Disease: Spotlight on Stem Cell Research – Leeza Gibbons – Video

10-06-2011 22:33 (Part 1 of 4) Robert Klein, JD and Leeza Gibbons, gave the welcoming remarks for the "Spotlight on Alzheimer's Disease," an educational event presented at the CIRM Governing Board meeting on December 10, 2008. Klein is Chair of the CIRM Governing Board and President of Klein Financial Corporation. Gibbons is a patient advocate member of the CIRM Governing Board and is the founder of the Leeza Gibbons Memory Foundation. The CIRM-hosted event was presented in partnership with the University of California, Irvine at the UC Irvine Student Center.

Excerpt from:
Alzheimer's Disease: Spotlight on Stem Cell Research - Leeza Gibbons - Video

Huntington's Disease: Spotlight on Stem Cell Research 2007 – Frances Saldana – Video

23-06-2011 16:50 (Part 4 of 4) Frances Saldana spoke at the "Spotlight on Huntington's Disease," an educational event presented at the CIRM Governing Board Meeting on December 12, 2007. Saldana spoke about the impact of Huntington's disease on her family. Saldana's daughter, a Huntington's disease patient, also spoke about the challenges of living with the disease. To view the other videos in this playlist, go to: http://www.youtube.com

See the article here:
Huntington's Disease: Spotlight on Stem Cell Research 2007 - Frances Saldana - Video

Huntington’s Disease: Spotlight on Stem Cell Research 2007 – Frances Saldana – Video

23-06-2011 16:50 (Part 4 of 4) Frances Saldana spoke at the "Spotlight on Huntington's Disease," an educational event presented at the CIRM Governing Board Meeting on December 12, 2007. Saldana spoke about the impact of Huntington's disease on her family. Saldana's daughter, a Huntington's disease patient, also spoke about the challenges of living with the disease. To view the other videos in this playlist, go to: http://www.youtube.com

See the article here:
Huntington's Disease: Spotlight on Stem Cell Research 2007 - Frances Saldana - Video

Huntington's Disease: Spotlight on Stem Cell Research 2007 – Han Keirstead – Video

23-06-2011 17:20 (Part 3 of 4) Hans Keirstead, Ph.D., spoke at the "Spotlight on Huntington's Disease," an educational event presented at the CIRM Governing Board meeting on December 12, 2007. Keirstead described strategies for using human embryonic stem cells to better understand Huntington's disease. He also explained the importance of generating highly purified human stem cell lines in a FDA-compliant manner that is scalable for future clinical use. Keirstead is co-director of the Sue and Bill Gross Stem Cell Research Center and associate professor of anatomy and neurobiology at the University of California, Irvine.

Read more from the original source:
Huntington's Disease: Spotlight on Stem Cell Research 2007 - Han Keirstead - Video

Huntington’s Disease: Spotlight on Stem Cell Research 2007 – Han Keirstead – Video

23-06-2011 17:20 (Part 3 of 4) Hans Keirstead, Ph.D., spoke at the "Spotlight on Huntington's Disease," an educational event presented at the CIRM Governing Board meeting on December 12, 2007. Keirstead described strategies for using human embryonic stem cells to better understand Huntington's disease. He also explained the importance of generating highly purified human stem cell lines in a FDA-compliant manner that is scalable for future clinical use. Keirstead is co-director of the Sue and Bill Gross Stem Cell Research Center and associate professor of anatomy and neurobiology at the University of California, Irvine.

Read more from the original source:
Huntington's Disease: Spotlight on Stem Cell Research 2007 - Han Keirstead - Video

Stem Cell Research: Huntington's Disease – Video

21-07-2011 14:02 Huntington's disease is an inherited neurodegenerative disorder that typically strikes in a person's thirties and leads to death about 10 to 15 years later. No effective therapy exists for the disease. Jan Nolta, director of the UC Davis Stem Cell Program and Institute for Regenerative Cures, has a CIRM Early Translational Award to develop stem cell-based therapies for Huntington's disease. Series: "California Institute for Regenerative Medicine" [Show ID: 22470]

View original post here:
Stem Cell Research: Huntington's Disease - Video

Stem Cell Research: Huntington’s Disease – Video

21-07-2011 14:02 Huntington's disease is an inherited neurodegenerative disorder that typically strikes in a person's thirties and leads to death about 10 to 15 years later. No effective therapy exists for the disease. Jan Nolta, director of the UC Davis Stem Cell Program and Institute for Regenerative Cures, has a CIRM Early Translational Award to develop stem cell-based therapies for Huntington's disease. Series: "California Institute for Regenerative Medicine" [Show ID: 22470]

View original post here:
Stem Cell Research: Huntington's Disease - Video

Stem Cell Treatment Kidney Disease – Video

07-11-2011 15:05 http://www.StemCellTreatment.org Kashka came down with actor Danny Glover and had stem cell treatment for kidney disease. He has been on dialyses for the last 4 years and is now feeling more energetic already after only his first stem cell treatment for kidney disease! Before coming to the American Stem Cell and Anti-Aging Center Kashka had tried every alternative means and then finally found ASCAAC on youtube and contacted us. We have had good results using stem cell therapy for kidney disease so please visit the website and give us a call! Kashka, un paciente de diálisis nos cyuenta como American Stem CEll le ha ayudado con sus problemas y cómo es parte de una nueva medicina de curación verdadera y no solo de lucha contra síntomas.

Read the rest here:
Stem Cell Treatment Kidney Disease - Video